Generation of Human Metabolites of 7-Ethoxycoumarin by Bacterial Cytochrome P450 BM3

Recently, wild-type and mutant forms of bacterial cytochrome P450 BM3 (CYP102A1) have been found to metabolize various drugs through reactions similar to those catalyzed by human cytochromes P450 (P450s). Therefore, it has been suggested that CYP102A1 may be used to produce large quantities of the metabolites of human P450-catalyzed reactions. In this report, we show that the oxidation of 7-ethoxycoumarin, a typical human P450 substrate, is catalyzed by both wild-type and mutant forms of CYP102A1. Two major products were produced as a result of O-deethylation and 3-hydroxylation reactions. These results demonstrate that CYP102A1 mutants catalyze the same reactions as human P450s. High noncompetitive intermolecular kinetic deuterium isotope effects were observed for 7-ethoxycoumarin O-deethylation in the CYP102A1 system. These results suggest that there is a common mechanism for the oxidation reactions catalyzed by both the bacterial CYP102A1 and human P450 enzymes.

[1]  F Peter Guengerich,et al.  Cytochromes P450 and drug discovery. , 2007, Current opinion in biotechnology.

[2]  Heung-Chae Jung,et al.  The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities. , 2007, Trends in biotechnology.

[3]  N. Vermeulen,et al.  Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis. , 2007, Journal of medicinal chemistry.

[4]  G. Gilardi,et al.  Wild-type CYP102A1 as a biocatalyst: turnover of drugs usually metabolised by human liver enzymes , 2007, JBIC Journal of Biological Inorganic Chemistry.

[5]  N. Vermeulen,et al.  Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3. , 2006, Biochemical and biophysical research communications.

[6]  Vlada B Urlacher,et al.  Cytochrome P450 monooxygenases: perspectives for synthetic application. , 2006, Trends in biotechnology.

[7]  R. Bernhardt,et al.  Cytochromes P450 as versatile biocatalysts. , 2006, Journal of biotechnology.

[8]  F. Arnold,et al.  Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3. , 2006, Journal of the American Chemical Society.

[9]  Chul-Ho Yun,et al.  Kinetic deuterium isotope effects for 7‐alkoxycoumarin O‐dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes , 2006, The FEBS journal.

[10]  F. Arnold,et al.  Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450. , 2006, Biotechnology and bioengineering.

[11]  Chris de Graaf,et al.  Role of the conserved threonine 309 in mechanism of oxidation by cytochrome P450 2D6. , 2005, Biochemical and biophysical research communications.

[12]  M. Hino,et al.  Oxidative activities of heterologously expressed CYP107B1 and CYP105D1 in whole-cell biotransformation using Streptomyces lividans TK24. , 2005, Journal of bioscience and bioengineering.

[13]  F. Guengerich,et al.  Kinetic Analysis of Oxidation of Coumarins by Human Cytochrome P450 2A6* , 2005, Journal of Biological Chemistry.

[14]  J. Ward,et al.  Enhanced Heterologous Expression of Two Streptomyces griseolus Cytochrome P450s and Streptomyces coelicolor Ferredoxin Reductase as Potentially Efficient Hydroxylation Catalysts , 2003, Applied and Environmental Microbiology.

[15]  Guengerich Fp Rate-limiting steps in cytochrome P450 catalysis. , 2002 .

[16]  F. Guengerich,et al.  Cytochrome p450 enzymes in the generation of commercial products , 2002, Nature Reviews Drug Discovery.

[17]  K. R. Marshall,et al.  P450 BM3: the very model of a modern flavocytochrome. , 2002, Trends in biochemical sciences.

[18]  R. Schmid,et al.  Engineering Cytochrome P450 BM-3 for Oxidation of Polycyclic Aromatic Hydrocarbons , 2001, Applied and Environmental Microbiology.

[19]  F. Arnold,et al.  Directed Evolution of a Cytochrome P450 Monooxygenase for Alkane Oxidation , 2001 .

[20]  L. Wong,et al.  Protein engineering of Bacillus megaterium CYP102. The oxidation of polycyclic aromatic hydrocarbons. , 2001, European journal of biochemistry.

[21]  G. Miller,et al.  Rate-determining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants. , 2000, Biochemistry.

[22]  L. Narhi,et al.  Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. , 1986, The Journal of biological chemistry.

[23]  A. Y. Lu,et al.  Kinetic isotope effects on cytochrome P-450-catalyzed oxidation reactions. The oxidative O-dealkylation of 7-ethoxycoumarin. , 1984, The Journal of biological chemistry.

[24]  A. Y. Lu,et al.  Kinetic isotope effects on cytochrome P-450-catalyzed oxidation reactions. Evidence for the irreversible formation of an activated oxygen intermediate of cytochrome P-448. , 1984, The Journal of biological chemistry.

[25]  L. Narhi,et al.  Phenobarbital induction of a soluble cytochrome P-450-dependent fatty acid monooxygenase in Bacillus megaterium. , 1982, The Journal of biological chemistry.

[26]  D. Northrop,et al.  Steady-state analysis of kinetic isotope effects in enzymic reactions. , 1975, Biochemistry.

[27]  A. Goldstein,et al.  Purification and properties , 1975 .

[28]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES. , 1964, The Journal of biological chemistry.

[29]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[30]  F. Guengerich,et al.  Rate-Limiting Steps in Cytochrome P450 Catalysis , 2002, Biological chemistry.

[31]  Armand,et al.  Phenobarbital Induction of a Soluble Cytochrome P-450-dependent Fatty Acid Monooxygenase in Bacillus megaterium * , 2001 .